{"schema_version":"secwatch.filing_event.v1","accession":"0001531177-25-000007","form_type":"8-K","ticker":"SGHT","cik":"0001531177","company_name":"Sight Sciences, Inc.","filed_at":"2025-08-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.248400+00:00","generated_at":"2026-05-17T09:41:41.162999+00:00","sec_items":["2.05","5.02","7.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Sight Sciences cuts 20% workforce; CCO departs; reaffirms FY revenue guidance","bullets":["Reduces headcount by 43 (~20% of global workforce); expects cash restructuring charge of $2.7M-$3.0M in Q3 2025.","CCO Matthew Link steps down effective Aug 31; eligible for severance including 1-year base salary and vesting of 61,675 RSUs.","Reaffirms FY2025 revenue guidance of $72M-$76M; updates adjusted opex guidance to $95M-$99M from $101M-$105M.","Annualized savings of ~$11.9M from workforce reductions alone.","Creates segment-specific leadership for Surgical Glaucoma and Dry Eye; delays certain R&D spend."],"urls":{"canonical":"https://secwatch.observer/filing/0001531177-25-000007","json":"https://secwatch.observer/filing/0001531177-25-000007.json","markdown":"https://secwatch.observer/filing/0001531177-25-000007.md","text":"https://secwatch.observer/filing/0001531177-25-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1531177/000153117725000007/0001531177-25-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1531177/000153117725000007/sght-20250827.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T09:41:41.162999+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"91ee87a5ec0ff218ba7cb4c5cc102e285858420c","claim":"Sight Sciences, Inc. announced a restructuring with charges of cash restructuring charge of approximately $2.7 million to $3.0 million primarily in the third quarter of 2025, consisting mostly of one-time employee severance affecting global operations, with specific changes in the United Kingdom (reduce its headcount by 43 employees, or approximately 20% of its global workforce, including up to four UK-based employ).","evidence_excerpt":"On August 27, 2025, Sight Sciences, Inc. (the “Company”) informed its employees that it is implementing a targeted plan, commencing immediately, intended to reduce operating expenses, improve cost efficiencies, and better align its operating structure for long-term, profitable growth (the “Plan”).","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1531177/000153117725000007/0001531177-25-000007-index.htm","confidence":0.95,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"cash restructuring charge of approximately $2.7 million to $3.0 million primarily in the third quarter of 2025, consisting mostly of one-time employee severance"},{"label":"Affected area","value":"global operations, with specific changes in the United Kingdom"},{"label":"Headcount","value":"reduce its headcount by 43 employees, or approximately 20% of its global workforce, including up to four UK-based employ"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}